Diferencia entre revisiones de «Template:Hemolytic anemia DDX»

Sin resumen de edición
 
(No se muestran 4 ediciones intermedias de otro usuario)
Línea 6: Línea 6:
*[[Heparin-Induced Thrombocytopenia (HIT)]]
*[[Heparin-Induced Thrombocytopenia (HIT)]]
*[[Hereditary spherocytosis]]
*[[Hereditary spherocytosis]]
*[[Paroxysmal nocturnal hemoglobinuria]]
*[[Paroxysmal nocturnal hemoglobinuria]] (PNH)
*[[malignant hypertension]]
*[[Malignant hypertension]]
*[[Scleroderma]]
*[[Antiphospholipid Syndrome (APS)]]
*[[Antiphospholipid Syndrome (APS)]]
*[[scleroderma]]
*Other medical causes: malignancy, renal allograft rejection, vasculitides like [[polyarteritis nodosa]] and [[Wegener's granulomatosis]]
*Other medical causes: malignancy, renal allograft rejection, vasculitides like [[polyarteritis nodosa]] and [[Wegener's granulomatosis]]
*Drugs: chemotherapy; [[Clopidogrel]] (Plavix) associated with [[TTP]]
*Drugs: chemotherapy; [[Clopidogrel]] (Plavix) associated with [[TTP]]
*Nonvascular causes: prosthetic valve (more common with mechanical, more common at aortic valve), [[LVAD]], [[TIPS]], coil embolization, patched AV shunt, [[AVM]])
*Nonvascular causes: prosthetic valve (more common with mechanical, more common at aortic valve), [[LVAD]], [[TIPS]], coil embolization, patched AV shunt, [[AVM]]

Revisión actual - 19:21 12 may 2019

Microangiopathic Hemolytic Anemia (MAHA)